Literature DB >> 12021518

Glomerular expression of alpha2(IV) and alpha5(IV) chains of type IV collagen in patients with IgA nephropathy.

Hirokazu Kamimura1, Kazuho Honda, Kosaku Nitta, Shigeru Horita, Hideo Kobayashi, Keiko Uchida, Yutaka Yamaguchi, Wako Yumura, Hiroshi Nihei.   

Abstract

IgA nephropathy (IgAN) frequently accompanies glomerular basement membrane (GBM) alterations. To clarify the compositional changes of the GBM in IgAN, we examined the glomerular expression of alpha2(IV) and alpha5(IV) chains of type IV collagen in 36 patients with IgAN. Increased expression of the alpha2(IV) chain was observed in the expanded mesangium, and there were segmental sclerotic lesions of glomeruli in which the expression of the alpha5(IV) chain in the GBM was reduced. These lesions were found in 11 out of the 36 patients (30.6%). The patients with these lesions had more proteinuria, lower creatinine clearance and severer histological changes than the patients without them. On the other hand, a partial reduction of alpha5(IV) chain in normal-appearing GBM was observed in 15 out of the 36 patients (41.7%). The patients with this lesion had a longer disease period before biopsy than the patients without it. No other clinical and histological parameters were related to the partial reduction of alpha5(IV) in the GBM. In conclusion, an imbalance of glomerular alpha2(IV) and alpha5(IV) chain expression occurred in IgAN. This may be associated with the morphological changes of glomerular sclerosis and GBM alterations in IgAN. Further studies are required to understand the pathogenesis of the abnormal expression of type IV collagen chains. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021518     DOI: 10.1159/000057603

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  5 in total

1.  Glomerular basement membrane (GBM) abnormalities are worth pursuing.

Authors:  Junko Takagi; Hiroyuki Morita; Koji Kimata
Journal:  Clin Exp Nephrol       Date:  2014-09-06       Impact factor: 2.801

2.  Glomerular basement membrane injuries in IgA nephropathy evaluated by double immunostaining for α5(IV) and α2(IV) chains of type IV collagen and low-vacuum scanning electron microscopy.

Authors:  Yukinari Masuda; Nobuaki Yamanaka; Arimi Ishikawa; Mitue Kataoka; Takashi Arai; Kyoko Wakamatsu; Naomi Kuwahara; Kiyotaka Nagahama; Kaori Ichikawa; Akira Shimizu
Journal:  Clin Exp Nephrol       Date:  2014-07-24       Impact factor: 2.801

3.  Utility of glomerular Gd-IgA1 staining for indistinguishable cases of IgA nephropathy or Alport syndrome.

Authors:  Shinya Ishiko; Akihito Tanaka; Asami Takeda; Masayuki Hara; Naoto Hamano; Masahiro Koizumi; Toshinori Ueno; Hiroki Hayashi; Atsushi Kondo; Sadayuki Nagai; Yuya Aoto; Nana Sakakibara; China Nagano; Tomoko Horinouchi; Tomohiko Yamamura; Takeshi Ninchoji; Yuko Shima; Koichi Nakanishi; Norishige Yoshikawa; Kazumoto Iijima; Kandai Nozu
Journal:  Clin Exp Nephrol       Date:  2021-03-20       Impact factor: 2.801

4.  Estimated glomerular filtration rate and daily amount of urinary protein predict the clinical remission rate of tonsillectomy plus steroid pulse therapy for IgA nephropathy.

Authors:  Keisuke Suzuki; Naoto Miura; Hirokazu Imai
Journal:  Clin Exp Nephrol       Date:  2013-09-20       Impact factor: 2.801

5.  Concurrent Anti-glomerular Basement Membrane Nephritis and IgA Nephropathy.

Authors:  Kwang-Sun Suh; Song-Yi Choi; Go Eun Bae; Dae Eun Choi; Min-Kyung Yeo
Journal:  J Pathol Transl Med       Date:  2019-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.